Name | Number of supported studies | Average coverage | |
---|---|---|---|
glutamatergic neuron | 5 studies | 48% ± 22% | |
GABAergic neuron | 5 studies | 44% ± 19% | |
oligodendrocyte precursor cell | 4 studies | 22% ± 6% | |
interneuron | 4 studies | 43% ± 24% | |
oligodendrocyte | 4 studies | 22% ± 6% | |
amacrine cell | 3 studies | 23% ± 1% | |
retina horizontal cell | 3 studies | 16% ± 1% | |
retinal cone cell | 3 studies | 19% ± 1% | |
retinal rod cell | 3 studies | 27% ± 8% | |
astrocyte | 3 studies | 23% ± 7% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 1545.45 | 2636 / 2642 | 99% | 4.78 | 699 / 705 |
thymus | 100% | 1412.07 | 653 / 653 | 99% | 6.85 | 596 / 605 |
prostate | 100% | 1011.33 | 245 / 245 | 96% | 2.59 | 484 / 502 |
adrenal gland | 98% | 530.52 | 254 / 258 | 97% | 10.32 | 222 / 230 |
kidney | 100% | 607.99 | 89 / 89 | 81% | 2.24 | 728 / 901 |
breast | 81% | 332.24 | 370 / 459 | 76% | 2.18 | 847 / 1118 |
pancreas | 73% | 203.47 | 241 / 328 | 75% | 2.06 | 133 / 178 |
uterus | 98% | 830.80 | 167 / 170 | 36% | 0.69 | 165 / 459 |
lung | 91% | 389.60 | 528 / 578 | 35% | 0.78 | 399 / 1155 |
bladder | 100% | 616.38 | 21 / 21 | 20% | 0.40 | 101 / 504 |
ovary | 100% | 1295.29 | 180 / 180 | 10% | 0.21 | 44 / 430 |
stomach | 93% | 402.60 | 333 / 359 | 14% | 0.24 | 40 / 286 |
intestine | 94% | 585.95 | 911 / 966 | 11% | 0.24 | 58 / 527 |
esophagus | 86% | 511.71 | 1243 / 1445 | 14% | 0.24 | 26 / 183 |
spleen | 100% | 720.35 | 241 / 241 | 0% | 0 | 0 / 0 |
blood vessel | 99% | 780.78 | 1328 / 1335 | 0% | 0 | 0 / 0 |
heart | 95% | 452.81 | 817 / 861 | 0% | 0 | 0 / 0 |
skin | 50% | 149.65 | 901 / 1809 | 32% | 0.61 | 150 / 472 |
liver | 56% | 144.50 | 126 / 226 | 17% | 0.28 | 69 / 406 |
adipose | 67% | 203.00 | 804 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 48% | 0.97 | 14 / 29 |
muscle | 44% | 112.62 | 352 / 803 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 36% | 0.50 | 16 / 45 |
eye | 0% | 0 | 0 / 0 | 35% | 0.66 | 28 / 80 |
peripheral blood | 13% | 32.51 | 119 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0045892 | Biological process | negative regulation of DNA-templated transcription |
GO_0017148 | Biological process | negative regulation of translation |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0000900 | Molecular function | mRNA regulatory element binding translation repressor activity |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO_0005515 | Molecular function | protein binding |
GO_0046872 | Molecular function | metal ion binding |
Gene name | ZNF540 |
Protein name | Zinc finger protein 540 |
Synonyms | hCG_1821866 Nbla10512 |
Description | FUNCTION: May act as a transcriptional repressor. . |
Accessions | ENST00000343599.5 [Q8NDQ6-1] ENST00000592533.5 [Q8NDQ6-1] Q8NDQ6 K7EK80 ENST00000589117.5 [Q8NDQ6-2] ENST00000586134.5 K7EQ46 ENST00000586792.5 K7ER55 ENST00000590588.5 ENST00000316433.9 [Q8NDQ6-1] |